Skip to contentK
Kraig Biocraft Laboratories, Inc.
K
KBLBKraig Biocraft Laboratories, Inc. Q1 2019 · 10-Q
Revenue$0.00$0.00−100.0% vs Q1 2018 Net Income-$477.75K-$477.75KN/M vs Q1 2018 EPS Diluted$0.00$0.00— vs Q1 2018 Operating Income-$412,010N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR
Free Cash Flowderived-$225,046N/M ended Mar 31, 2019 · filed May 13, 2019 · 43 d after period end